Medicare Enrolled

Dr. Eman Albaddawi, M.D

Pulmonary Disease · Sacramento, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
3000 Q ST FL 2, Sacramento, CA 95816
9167333323
In practice since 2010 (15 years)
NPI: 1730490053 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Albaddawi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Albaddawi? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Albaddawi

Dr. Eman Albaddawi is a pulmonary disease specialist in Sacramento, CA, with 15 years of NPI registration. Based on federal Medicare data, Dr. Albaddawi performed 982 Medicare services across 778 unique beneficiaries.

Between the years covered by Open Payments, Dr. Albaddawi received a total of $5,964 from 30 pharmaceutical and/or device companies across 277 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Albaddawi is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 15 years in practice ▲ Top 38% volume in CA $5,964 industry payments

Medicare Practice Summary

Medicare Utilization ↗
982
Medicare services
Top 38% in CA for pulmonary disease
778
Unique beneficiaries
$79
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~65 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
436 $98 $250
Spirometry test before and after medication
A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication.
108 $7 $32
Lung volume test using sensors
A test that measures the amount of air in the lungs using sensors.
101 $9 $35
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
89 $135 $379
Exercise-induced lung stress test
A test performed to evaluate how the lungs function during physical exertion. It helps identify breathing difficulties or lung conditions that occur specifically when exercising.
79 $26 $89
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
64 $125 $328
New patient office visit, complex (60-74 min) 56 $168 $469
Smoking cessation counseling, 4-10 minutes
A brief counseling session focused on helping patients quit smoking and tobacco use. The provider spends 4 to 10 minutes discussing strategies and support for cessation.
28 $15 $34
Telephone medical discussion, 21-30 minutes
A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone.
21 $69 $280
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$5,964
Total received (2018-2024)
Avg $852/year across 7 years
Top 25% in CA for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
30
Companies
277
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,557 (93.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$407 (6.8%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,003
2023
$2,295
2022
$1,422
2021
$418
2020
$488
2019
$294
2018
$45

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Regeneron Healthcare Solutions, Inc.
$255
GlaxoSmithKline, LLC.
$148
AstraZeneca Pharmaceuticals LP
$146
Boehringer Ingelheim Pharmaceuticals, Inc.
$85
Takeda Pharmaceuticals U.S.A., Inc.
$68
Mylan Specialty L.P.
$60
Baxter Healthcare
$49
Amgen Inc.
$46
JAZZ PHARMACEUTICALS INC.
$33
Lilly USA, LLC
$20
Insmed, Inc.
$19
Otsuka America Pharmaceutical, Inc.
$18
United Therapeutics Corporation
$17
Paratek Pharmaceuticals, Inc.
$15
Merck Sharp & Dohme LLC
$15
Electromed, Inc.
$8
Top 3 companies account for 54.7% of 2024 payments
All-time payments by company (2018-2024) ›
GlaxoSmithKline, LLC.
$1,161
Boehringer Ingelheim Pharmaceuticals, Inc.
$724
AstraZeneca Pharmaceuticals LP
$715
Regeneron Healthcare Solutions, Inc.
$694
United Therapeutics Corporation
$358
Actelion Pharmaceuticals US, Inc.
$297
Mylan Specialty L.P.
$249
Grifols USA, LLC
$203
Takeda Pharmaceuticals U.S.A., Inc.
$172
Philips Electronics North America Corporation
$139
Astellas Pharma US Inc
$135
Electromed, Inc.
$126
Baxter Healthcare
$121
GENZYME CORPORATION
$120
Amgen Inc.
$115
Janssen Pharmaceuticals, Inc
$95
Genentech USA, Inc.
$93
PFIZER INC.
$90
Advanced Respiratory, Inc
$60
Covis Pharma GmBH
$45
Teva Pharmaceuticals USA, Inc.
$36
Bayer HealthCare Pharmaceuticals Inc.
$35
JAZZ PHARMACEUTICALS INC.
$33
Merck Sharp & Dohme LLC
$31
CSL Behring
$30
Lilly USA, LLC
$20
Insmed, Inc.
$19
Otsuka America Pharmaceutical, Inc.
$18
Paratek Pharmaceuticals, Inc.
$15
Novartis Pharmaceuticals Corporation
$15
Top 3 companies account for 43.6% of all-time payments
Associated products mentioned in payments ›
(1635) US Standard Basic SV · AIRSUPRA · ALVESCO · ANORO ELLIPTA · AREXVY · Adempas · AirDuo Digihaler · AmBisome · Arikayce · BREZTRI · Cresemba · DUPIXENT · ELIQUIS · FASENRA · GLASSIA · HYQVIA · Hillrom - Life 2000 Ventilation System · Hillrom - Vest System Model 105 Home Care · Hizentra · MOUNJARO · NUCALA · NUZYRA · OFEV · OPSUMIT · ORENITRAM · PANZYGA · Prolastin-C Liquid · REXULTI · SMARTVEST · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SYMBICORT · TEZSPIRE · TRELEGY ELLIPTA · TRUMENBA · TYVASO · The Vest System Model 105 Home Care · UPTRAVI · WINREVAIR · XARELTO · XOLAIR · XYWAV · Xolair · YUPELRI · Yupelri
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (93%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a pulmonary disease specialist in Sacramento?
Compare pulmonary diseases in the Sacramento area by procedure volume, costs, and industry payment transparency.
Browse pulmonary diseases nearby

Geographic Context

Pulmonary diseases within 10 mi
38
Per 100K population
2.4
County median income
$88,724
Nearest hospital
SUTTER MEDICAL CENTER, SACRAMENTO
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Albaddawi is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 15 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Albaddawi experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Albaddawi performed 436 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Albaddawi receive payments from pharmaceutical companies?
Yes. Dr. Albaddawi received a total of $5,964 from 30 companies across 277 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Albaddawi's costs compare to other pulmonary diseases in Sacramento?
Dr. Albaddawi's average Medicare payment per service is $79. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Albaddawi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →